128 related articles for article (PubMed ID: 197984)
1. Plasma concentration and pharmacological effects of pyridostigmine in patients with myasthenia gravis [proceedings].
Calvey TN; Chan K
Br J Clin Pharmacol; 1977 Jun; 4(3):404P. PubMed ID: 197984
[No Abstract] [Full Text] [Related]
2. Plasma concentration of pyridostigmine and effects in myastenia gravis.
Chan K; Calvey TN
Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):596-601. PubMed ID: 199393
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular function and plasma drug levels in pyridostigmine treatment of myasthenia gravis.
Breyer-Pfaff U; Schmezer A; Maier U; Brinkmann A; Schumm F
J Neurol Neurosurg Psychiatry; 1990 Jun; 53(6):502-6. PubMed ID: 2166138
[TBL] [Abstract][Full Text] [Related]
4. Quantitative correlation between plasma pyridostigmine levels and neuromuscular function in myasthenia gravis.
Milner-Brown HS; Mellenthin M; Sharma ML; Miller RG
Neurology; 1987 May; 37(5):800-3. PubMed ID: 3574680
[TBL] [Abstract][Full Text] [Related]
5. [Serum levels of pyridostigmine in myasthenia gravis: methods and clinical significance].
Schumm F; Gaertner HJ; Wiatr G; Dichgans J
Fortschr Neurol Psychiatr; 1985 Jun; 53(6):201-11. PubMed ID: 2991094
[TBL] [Abstract][Full Text] [Related]
6. Pyridostigmine levels in myasthenia gravis.
Kornfeld P; Mittag T; Genkins G; Papatestas AE; Horowitz SH
Neurology; 1977 Nov; 27(11):1099. PubMed ID: 563008
[No Abstract] [Full Text] [Related]
7. Plasma pyridostigmine levels in patients with myasthenia gravis.
Calvey TN; Chan K
Clin Pharmacol Ther; 1977 Feb; 21(2):187-93. PubMed ID: 837637
[TBL] [Abstract][Full Text] [Related]
8. Effects on neuromuscular function of acute chronic exposure to cholinesterase inhibitors in man and in the rat.
Roberts DV; Taylor K; Wilson A
J Physiol; 1971 Dec; 219(2):15P. PubMed ID: 4333825
[No Abstract] [Full Text] [Related]
9. Atypical myasthenia gravis. A neurophysiological and pharmacological study.
Bergmans J; Cleppe D; Diniz P; Rosselle N
Electromyogr Clin Neurophysiol; 1975 Jul; 15(3):271-7. PubMed ID: 173519
[No Abstract] [Full Text] [Related]
10. Neuromuscular blockade.
Neigh JL
Surg Clin North Am; 1975 Aug; 55(4):837-50. PubMed ID: 241125
[No Abstract] [Full Text] [Related]
11. The effect of chronic pyridostigmine administration on pyridostigmine-14C metabolism in myasthenia gravis.
Kornfeld P; Wolf RL; Samuels AJ; Osserman KE
Neurology; 1971 May; 21(5):550-2. PubMed ID: 5104099
[No Abstract] [Full Text] [Related]
12. The relationship of plasma levels of pyridostigmine to clinical effect in patients with myasthenia gravis.
Davison SC; Hyman NM; Dehghan A; Chan K
J Neurol Neurosurg Psychiatry; 1981 Dec; 44(12):1141-5. PubMed ID: 7334410
[TBL] [Abstract][Full Text] [Related]
13. Plasma pyridostigmine levels in myasthenia gravis.
White MC; De Silva P; Havard CW
Neurology; 1981 Feb; 31(2):145-50. PubMed ID: 7193298
[TBL] [Abstract][Full Text] [Related]
14. Repetitive stimulation in myasthenia gravis: decrementing response revealed by anticholinesterase drugs.
Scoppetta C; Casali C; D'Agostini S; La Cesa I; Parisi L
Electroencephalogr Clin Neurophysiol; 1990 Feb; 75(2):122-4. PubMed ID: 1688768
[TBL] [Abstract][Full Text] [Related]
15. Improvement in neuromuscular transmission in myasthenia gravis by 3,4-diaminopyridine.
Lundh H; Nilsson O; Rosén I
Eur Arch Psychiatry Neurol Sci; 1985; 234(6):374-7. PubMed ID: 2992990
[TBL] [Abstract][Full Text] [Related]
16. Suxamethonium block in the myasthenic patient. Correlation with plasma cholinesterase.
Baraka A
Anaesthesia; 1992 Mar; 47(3):217-9. PubMed ID: 1314525
[TBL] [Abstract][Full Text] [Related]
17. Effect of dibutyryl cyclic AMP on neuromuscular transmission in myasthenia gravis.
Hashimoto Y; Sasaki H; Iwatsuki K
Tohoku J Exp Med; 1976 Oct; 120(2):197-8. PubMed ID: 185750
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of verapamil on neuromuscular transmission in patients with myasthenia gravis.
Lee SC; Ho ST
Proc Natl Sci Counc Repub China B; 1987 Jul; 11(3):307-12. PubMed ID: 2827211
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis.
Gehi A; Benatar M; Langberg J
J Cardiovasc Electrophysiol; 2008 Feb; 19(2):214-6. PubMed ID: 17711430
[TBL] [Abstract][Full Text] [Related]
20. Acute changes in respiratory mechanics after pyridostigmine injection in patients with myasthenia gravis.
De Troyer A; Borenstein S
Am Rev Respir Dis; 1980 Apr; 121(4):629-38. PubMed ID: 7386976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
